Mon, Sep 1, 2014, 4:41 AM EDT - U.S. Markets closed for Labor Day

Recent

% | $
Quotes you view appear here for quick access.

Horizon Pharma, Inc. (HZNP) Message Board

  • dripshark dripshark Jun 1, 2012 1:14 PM Flag

    HZNP targeted for buyout?

    Lodotra, currently under FDA review "the company anticipates an approval decision on July 26, 2012."

    New revenue streams already doing well cash on the books... Merck ready to jump?

    I wonder with all these buys if the conversations with Merck are leading to something?

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Could you provide more info on the conversations with Merck?

      • 2 Replies to stocks4u_000000000000
      • Look here: http://www.evaluatepharma.com/Universal/View.aspx?type=Report&id={E7C7352F-412E-41AC-B9F2-161E42D7003C}¶ms=%3CPARAMS%20currencyId=%220%22%3E%3CPARAM%20linkKind=%220%22%20compId=%22co%22%20name=%22kgaa%20+merck%22%20itemId=%221042%22%20/%3E%3C/PARAMS%3E&more=true

      • Merck KGaA holds marketing rights to LODOTRA® in Germany and Austria, and Mundipharma holds marketing rights to LODOTRA® in the rest of Europe.

        The company has completed a Phase 3 trial for LODOTRA® in the U.S. for the treatment of the signs and symptoms of RA. In the pivotal U.S. Phase 3 clinical study (CAPRA-2), patients treated with LODOTRA® experienced a statistically significant improvement in ACR-20 response when compared with patients in the placebo group (48.5 percent vs. 28.6 percent; p=0.0002). In addition, patients taking LODOTRA® experienced a statistically significant improvement in ACR-50 response (22.7 percent vs. 9.2 percent; p=0.0027). Importantly, patients treated with LODOTRA® also experienced a statistically significant reduction in morning stiffness when compared with patients in the placebo group (44 percent vs. 21 percent; p=0.0008).

        LODOTRA® is also being investigated for the treatment of severe asthma and polymyalgia rheumatica (PMR).

        Merck wants the U.S. rights as far as I know

        My opinion

 
HZNP
10.30+0.14(+1.38%)Aug 29 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Avago Technologies Limited
NasdaqGSFri, Aug 29, 2014 4:00 PM EDT
Splunk, Inc.
NasdaqGSFri, Aug 29, 2014 4:00 PM EDT